Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas

KLÁNOVÁ, M., KAZANTSEV, D., POKORNÁ, E., ZIKMUND, T., KAROLOVÁ, J., BEHOUNEK, M., RENESOVA, N., SOVILJ, D., KELEMEN, C., HELMAN, K., JAKSA, R., HAVRÁNEK, O., ANDĚRA, L., TRNĚNÝ, M., KLENER, P. Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics. 2022, 21(1), 89-99. ISSN 1535-7163. E-ISSN 1538-8514. Dostupné z: doi: 10.1158/1535-7163.MCT-21-0511.